Biofusion Therapeutics Limited
About Biofusion Therapeutics Limited
Data last updated: 26 July 2025
Biofusion Therapeutics Limited was a public limited company based in Bengaluru, Karnataka, India, operated as a subsidiary of Biocon Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in biotechnology, a part of the broader life sciences sector. Incorporated on 18 March 2021.
Registered with ROC Bangalore under CIN U73100KA2021PLC145487.
Capital: an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Kiran Mazumdar Shaw and Siddharth Mittal.
Last AGM: 11 August 2023. Financial statements filed for year ended 31 March 2023. Office: Bengaluru, Karnataka.
As per the financials filed for FY 2023, the company reported a revenue of ₹56.53 Cr, a growth of 41% compared to the previous year.
The company had a reported workforce of approximately 3 employees prior to being dissolved. It operated as a subsidiary of Biocon Limited.
As per MCA filings, the company had satisfied charges of ₹42.71 Cr on record.
The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered Address4Th Floor Pod2 Brc Building Biocon Special Economic Zone Bommasandra Industrial Ar, Ea, Bengaluru, Karnataka, India – 560099
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Business Activity of Biofusion Therapeutics Limited
Biofusion Therapeutics Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Biofusion Therapeutics Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Biofusion Therapeutics Limited
Biofusion Therapeutics Limited is audited by B S R & Co. LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B S R & Co. LLP | Locked | Locked | Locked |
Complete auditor history for Biofusion Therapeutics Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Biofusion Therapeutics Limited
Biofusion Therapeutics Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Mazumdar Shaw | Director | 18 Mar 2021 | 5 Years 4 Months | As last reported |
|
Siddharth Mittal
Also directs:
Syngene International Limited, Biocon Pharma Limited, Biocon Biosphere Limited and 1 more
|
Director | 18 Mar 2021 | 5 Years 4 Months | As last reported |
|
Karaikal Narayanaswamy Murali Krishnan
Also directs:
Biocon Pharma Limited, Biocon Biosphere Limited
|
Director | 27 Jul 2022 | 3 Years 11 Months | As last reported |
Financials of Biofusion Therapeutics Limited FY 2023 filings available
Biofusion Therapeutics Limited reported revenue of ₹56.53 Cr (up 41.00% YoY) for FY 2023.
Ten-year financial statements for Biofusion Therapeutics Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Biofusion Therapeutics Limited
Shareholding and ownership data for Biofusion Therapeutics Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Biofusion Therapeutics Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Apr 2022 | Citi Bank N.A. | ₹42.71 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Biofusion Therapeutics Limited
Biofusion Therapeutics Limited has a workforce of 3 employees as of Mar 29, 2024.
Employee and EPFO history for Biofusion Therapeutics Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Biofusion Therapeutics Limited
GST registrations and filing compliance for Biofusion Therapeutics Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Biofusion Therapeutics Limited
Credit ratings, litigation, and regulatory alerts for Biofusion Therapeutics Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biofusion Therapeutics Limited
MSME payment history for Biofusion Therapeutics Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biofusion Therapeutics Limited
Corporate group structure for Biofusion Therapeutics Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biofusion Therapeutics Limited
MCA filings and documents for Biofusion Therapeutics Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Biofusion Therapeutics Limited
Frequently Asked Questions about Biofusion Therapeutics Limited
Biofusion Therapeutics Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Biofusion Therapeutics Limited is a amalgamated public limited company in the life sciences sector based in Bengaluru, Karnataka, India. It was incorporated on 18 March 2021 and is registered under CIN U73100KA2021PLC145487. The company was amalgamated as per MCA records and no longer exists as a legal entity.
Biofusion Therapeutics Limited was incorporated on 18 March 2021. Registered with ROC Bangalore.
The current directors of Biofusion Therapeutics Limited are:
- Kiran Mazumdar Shaw - Director
- Siddharth Mittal - Director
- Karaikal Narayanaswamy Murali Krishnan - Director
The CIN (Corporate Identification Number) of Biofusion Therapeutics Limited is U73100KA2021PLC145487. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Biofusion Therapeutics Limited is life sciences. The company specifically operates in biotechnology.